Cytodyn, Inc.

This study tested a drug called leronlimab combined with chemotherapy (carboplatin) in people with a specific type of advanced triple-negative breast cancer that has spread. Only 10 patients were enrolled before the trial was stopped early. The goal was to find a safe dose and se…

This study looked at the long-term effects of a weekly injection called PRO 140, given with standard HIV medications, to keep the virus under control. It enrolled 43 people with HIV who had already completed earlier PRO 140 studies. The trial was terminated early, so results are …

This study looked at whether a drug called PRO 140 could keep HIV under control when used alone (without other HIV meds) over a long period. It included 56 adults with HIV who had already been on PRO 140 for 48 weeks and had undetectable virus levels. The study was stopped early,…

This study tested whether a monthly injection of an antibody called PRO 140 could keep HIV under control without daily pills. It included 20 adults with HIV who had stable virus levels on standard therapy. The goal was to see how long the virus stayed suppressed after switching t…